Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.
about
Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus)Pathogenesis of human immunodeficiency virus infectionEpidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougarsCell-associated transmission of HIV type 1 and other lentiviruses in small-animal modelsEmerging viruses in the Felidae: shifting paradigmsPharmacological inhibition of feline immunodeficiency virus (FIV)Recent developments in human immunodeficiency virus-1 latency researchUnderstanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency virusesFeline immunodeficiency virus Vif localizes to the nucleusCrossing the species barrier--viruses and the origins of AIDS in perspectiveStructural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV proteaseCats are not small dogs: is there an immunological explanation for why cats are less affected by arthropod-borne disease than dogs?Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency virusesHP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses HMutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidineAnalysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivoWorldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspectsNucleotide sequence and genomic organization of feline immunodeficiency virus.Crystal structure of dUTP pyrophosphatase from feline immunodeficiency virus.Animal models for HIV/AIDS researchPathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions.Prevalence and risk factors of feline leukaemia virus and feline immunodeficiency virus in peninsular MalaysiaGoing wild: lessons from naturally occurring T-lymphotropic lentivirusesFeline Immunodeficiency Virus Cross-Species Transmission: Implications for Emergence of New Lentiviral Infections.DNA recombination and natural selection pressure sustain genetic sequence diversity of the feline MHC class I genes.Comparison of two host cell range variants of feline immunodeficiency virus.Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activityA conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.FIV Gag: virus assembly and host-cell interactions.Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: Prevalence, disease associations, and survival analysis.A detailed phylogenetic analysis of FIV in the United States.Comparative genome organization of human, murine, and feline MHC class II regionFeline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma.Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome.Expression of reverse transcriptase from feline immunodeficiency virus in Escherichia coli.Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2',3'-dideoxyinosine alone and in combination with 3'-azido-3'-deoxythymidineA novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidineNeurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression.
P2860
Q21090069-B48EDC97-243C-4D28-ACFF-7FE5697D8ACDQ24634681-7E9F3ED5-596D-4419-BAD9-829CE0FE49C7Q24682961-1855648A-ADCE-4C2D-88C1-07DCAA44A965Q26824485-081F117D-82C5-4E56-B3AD-D8A9005F8B5EQ26849332-EFC7F4A7-94ED-43E6-9E5B-0F4D056EC0C2Q26995310-7F6FB6DE-3557-484D-9D54-A1414CD9B47FQ27013114-EF5E30D5-39AF-4D76-A5E5-0C86B20CC768Q27021655-54F3D418-02AC-4E17-85DA-CAA03D752536Q27469637-10B101ED-D4B2-4FD1-B0DB-E7710745E6EAQ27472719-D38FCF66-B6A4-4293-B267-C7934F7EB29CQ27621075-8E7BD6A7-B849-4626-9B32-7F1A62F4AE85Q28077205-7B2853EA-C436-4C69-954A-FB86F943FB08Q28323510-E3EC8301-E7E9-4E92-956D-CD31CD95E262Q28324003-41CC197E-1912-421B-87F6-B3AE2385502CQ28326866-D4161314-8AC0-4CFC-ACEA-72ED1121511CQ28379312-2FA9AE5A-650E-4358-B4C6-4F1B48C37A91Q28776741-F013DAEB-173A-4D7A-A4A2-B9B7D40131CAQ30011272-E1FD5729-D13C-4502-A740-1226F72BF424Q30176729-3C5B1D62-62F8-41DA-B818-0F39F216681FQ30423656-018A6FBA-36BE-42C6-AD1B-BD0F80D8F710Q30491371-3F6E02EF-802B-473C-AC4E-F919B700616FQ31052765-127A36BA-EE42-4457-9E23-F29BD70EFFBAQ31066870-5D8C17B7-C631-48A4-8C3A-C5F844224181Q31150529-840CBF31-0E2D-497D-A616-806EABD01F13Q33256586-7CBEBB7C-F93F-4305-8411-F74F79F5D73CQ33257781-A34787C6-3A00-4158-82DA-9D05BF1E6114Q33587317-F17DF0C3-67AF-490F-827D-66A107C80879Q33639678-F6BEC6DF-4448-4E61-9D10-9D01FEA1CE9BQ33651576-380B43CB-7DE6-4F40-8EE0-7DFD7948CE9FQ33653971-90136A6A-ECE9-4D07-853B-2DC509765031Q33655001-60C1CB0F-07D5-4763-A8ED-9CFB4B564287Q33658513-3A3C3118-663B-4141-89AA-5D7D329398CEQ33677107-EEC6EBAD-3D72-44FE-800B-EFD731BFD5DBQ33690901-E4DA327B-EFD2-4D44-A939-4A4C46B7F64BQ33723871-78735309-AAFC-4AA0-BA62-2F412A7D1BA3Q33742501-DAFE030D-7362-47D3-8225-F46A7318BB11Q33750039-9B7826EE-E797-4088-B517-555F89049636Q33753465-ABB4C452-7C61-4462-95C8-B0CB1ED192BCQ33782477-0215B362-C84B-4C95-B958-1ED48E54102FQ33785394-50E507C5-93E7-48AC-A2B5-67C9651E4339
P2860
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@ast
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@en
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@nl
type
label
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@ast
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@en
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@nl
prefLabel
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@ast
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@en
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@nl
P2093
P356
P1433
P1476
Isolation of a T-lymphotropic ...... mmunodeficiency-like syndrome.
@en
P2093
P304
P356
10.1126/SCIENCE.3643650
P407
P577
1987-02-01T00:00:00Z